Charleston Hematology Oncology Associates Pa — Charleston, South Carolina

Charleston Hematology Oncology Associates Pa is a clinical research site located in Charleston, South Carolina, United States 29414.

Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.

Charleston Hematology Oncology Associates Pa has participated in 30 clinical trials.

Therapeutic areas: Non Small Cell Lung Cancer ALK Positive or ROS1 Positive, Multiple Myeloma, Non-Small-Cell Lung Cancer.

Sponsors: Pfizer, Celgene, Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Charleston

Browse all research sites in South Carolina · View every site in Charleston

Sponsor Feasibility Report

Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Charleston Hematology Oncology Associates Pa?

Charleston Hematology Oncology Associates Pa has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Charleston Hematology Oncology Associates Pa conducted?

Charleston Hematology Oncology Associates Pa has 30 clinical trials on record. Their work covers Non Small Cell Lung Cancer ALK Positive or ROS1 Positive, Multiple Myeloma, Non-Small-Cell Lung Cancer.

Is Charleston Hematology Oncology Associates Pa accredited by Crixeo Clinical Trials?

Charleston Hematology Oncology Associates Pa has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Charleston Hematology Oncology Associates Pa?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.